Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.
Jun 26, 2023
0
47
Finding evidence of what is known as "anchoring bias," UCLA-led research suggests that patients with congestive heart failure experiencing shortness of breath are less likely to be tested in the emergency department for a ...
Jun 26, 2023
0
25
The Child Tax Credit expansion, which expired at the end of 2021, has not been renewed due to concerns among legislators over the credit being overly generous, particularly to lower-income families with limited tax liability, ...
Jun 24, 2023
0
54
Highly targeted electrical stimulation to the brain showed promise as a new treatment for the most common type of stroke, according to a pilot study led by UCLA Health researchers.
Jun 21, 2023
0
82
Treating a mouse model of multiple sclerosis with the pregnancy hormone estriol reversed the breakdown of myelin in the brain's cortex, a key region affected in multiple sclerosis, according to a new UCLA Health study published ...
Jun 15, 2023
0
24
Child care challenges and financial stresses during the pandemic may have greatly diminished opportunities for California parents to interact with their youngest children, according to a study published today by the UCLA ...
Jun 14, 2023
0
4
A statewide pay-for-performance intervention based on a set of guidelines called Choosing Wisely reduced rates of inappropriate antibiotic prescriptions to treat acute respiratory tract infections by an average of 18 percentage ...
Jun 12, 2023
0
3
Scientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organoids that are designed to mimic the function and architecture of real tumors. The improved process ...
Jun 6, 2023
0
37
In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests ...
Jun 5, 2023
0
70
A study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is added to hormone therapy there are a significant invasive disease-free survival benefit in patients ...
Jun 2, 2023
0
7
